These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 8972547)

  • 1. Rebound responding following a single dose of drug using an amphetamine-vehicle-haloperidol drug discrimination.
    Caul WF; Barrett RJ; Huffman EM; Stadler JR
    Psychopharmacology (Berl); 1996 Dec; 128(3):274-9. PubMed ID: 8972547
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterizing withdrawal in rats following repeated drug administration using an amphetamine-vehicle-haloperidol drug discrimination.
    Stadler JR; Caul WF; Barrett RJ
    Psychopharmacology (Berl); 1999 Apr; 143(3):219-26. PubMed ID: 10353423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amphetamine-induced withdrawal responding: effects of repeated drug administration.
    Caul WF; Stadler JR; Barrett RJ
    Psychopharmacology (Berl); 1997 Oct; 133(4):351-5. PubMed ID: 9372534
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-lasting rebound cue effects following single doses of nicotine and amphetamine: implications for understanding tolerance.
    Barrett RJ; Caul WF; Stadler JR; Smith RL
    Psychopharmacology (Berl); 2001 Oct; 157(4):349-57. PubMed ID: 11605093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schedule-dependent effects of haloperidol and amphetamine: multiple-schedule task shows within-subject effects.
    Caul WF; Brindle NA
    Pharmacol Biochem Behav; 2001 Jan; 68(1):53-63. PubMed ID: 11274708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amphetamine-haloperidol discrimination: effects of chronic drug treatment.
    Haenlein M; Caul WF; Barrett RJ
    Pharmacol Biochem Behav; 1985 Dec; 23(6):949-52. PubMed ID: 4080781
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dopaminergic basis for the facilitation of brain stimulation reward by the NMDA receptor antagonist, MK-801.
    Olds ME
    Eur J Pharmacol; 1996 Jun; 306(1-3):23-32. PubMed ID: 8813611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of aripiprazole on operant responding for a natural reward after psychostimulant withdrawal in rats.
    Schwabe K; Koch M
    Psychopharmacology (Berl); 2007 Apr; 191(3):759-65. PubMed ID: 16953383
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Withdrawal, tolerance, and sensitization to dopamine mediated interoceptive cues in rats trained on a three-lever drug-discrimination task.
    Barrett RJ; Caul WF; Smith R
    Pharmacol Biochem Behav; 2005 May; 81(1):1-8. PubMed ID: 15894057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rebound cue state following a single dose of haloperidol.
    Caul WF; Jones JR; Schmidt TA; Murphy SM; Barrett RJ
    Life Sci; 1991; 49(17):PL119-24. PubMed ID: 1943434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the dopamine autoreceptor antagonist (-)-DS121 on the discriminative stimulus properties of d-amphetamine and cocaine.
    Clark D; Exner M; Furmidge LJ; Svensson K; Sonesson C
    Eur J Pharmacol; 1995 Feb; 275(1):67-74. PubMed ID: 7774664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. D2-specific discriminative stimuli: parameters, blocking, and rebound.
    Huffman EM; Caul WF; Strand EJ; Jones JR; Barrett RJ
    Pharmacol Biochem Behav; 1995 May; 51(1):77-82. PubMed ID: 7617736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of repeated haloperidol administration on phencyclidine discrimination in rats.
    Wiley JL
    Prog Neuropsychopharmacol Biol Psychiatry; 1995 Jul; 19(4):699-711. PubMed ID: 8588067
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenosine A(2A) receptor antagonism reverses the effects of dopamine receptor antagonism on instrumental output and effort-related choice in the rat: implications for studies of psychomotor slowing.
    Farrar AM; Pereira M; Velasco F; Hockemeyer J; Müller CE; Salamone JD
    Psychopharmacology (Berl); 2007 Apr; 191(3):579-86. PubMed ID: 17072593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for bidirectional cues as a function of time following treatment with amphetamine: implications for understanding tolerance and withdrawal.
    Barrett RJ; Caul WF; Smith RL
    Pharmacol Biochem Behav; 2004 Dec; 79(4):761-71. PubMed ID: 15582685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bidirectional effects of dopamine D2 receptor antagonists on responding for a conditioned reinforcer.
    Smith JK; Neill JC; Costall B
    Pharmacol Biochem Behav; 1997 Aug; 57(4):843-9. PubMed ID: 9259014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of the adenosine A₂A agonist CGS-21680 and haloperidol on food-reinforced fixed ratio responding in the rat.
    Jones-Cage C; Stratford TR; Wirtshafter D
    Psychopharmacology (Berl); 2012 Mar; 220(1):205-13. PubMed ID: 21898173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of GABA agonists and GABA-A receptor modulators on cocaine- and food-maintained responding and cocaine discrimination in rats.
    Barrett AC; Negus SS; Mello NK; Caine SB
    J Pharmacol Exp Ther; 2005 Nov; 315(2):858-71. PubMed ID: 16033912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug discrimination in rats: evidence for amphetamine-like cue state following chronic haloperidol.
    Barrett RJ; Steranka LR
    Pharmacol Biochem Behav; 1983 Apr; 18(4):611-7. PubMed ID: 6867066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopamine receptor antagonists reverse amphetamine-induced behavioral alteration on a differential reinforcement for low-rate (DRL) operant task in the rat.
    Cheng RK; Liao RM
    Chin J Physiol; 2007 Apr; 50(2):77-88. PubMed ID: 17608145
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.